211 related articles for article (PubMed ID: 26878132)
21. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease.
Jones M; Peden AH; Yull H; Wight D; Bishop MT; Prowse CV; Turner ML; Ironside JW; MacGregor IR; Head MW
Transfusion; 2009 Feb; 49(2):376-84. PubMed ID: 18980616
[TBL] [Abstract][Full Text] [Related]
22. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
[TBL] [Abstract][Full Text] [Related]
23. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.
Kim C; Haldiman T; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Safar JG
PLoS Pathog; 2011 Sep; 7(9):e1002242. PubMed ID: 21931554
[TBL] [Abstract][Full Text] [Related]
24. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
25. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.
Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T
J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151
[TBL] [Abstract][Full Text] [Related]
26. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.
Bishop MT; Will RG; Manson JC
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):12005-10. PubMed ID: 20547859
[TBL] [Abstract][Full Text] [Related]
27. Creutzfeldt-Jakob disease.
Sikorska B; Knight R; Ironside JW; Liberski PP
Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
[TBL] [Abstract][Full Text] [Related]
29. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
[TBL] [Abstract][Full Text] [Related]
30. Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay.
Jones M; Peden AH; Wight D; Prowse C; Macgregor I; Manson J; Turner M; Ironside JW; Head MW
Neuroreport; 2008 Dec; 19(18):1783-6. PubMed ID: 18955905
[TBL] [Abstract][Full Text] [Related]
31. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan.
Fukushima R; Shiga Y; Nakamura M; Fujimori J; Kitamoto T; Yoshida Y
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):485-7. PubMed ID: 14966171
[TBL] [Abstract][Full Text] [Related]
32. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
[TBL] [Abstract][Full Text] [Related]
33. Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.
Mead S; Joiner S; Desbruslais M; Beck JA; O'Donoghue M; Lantos P; Wadsworth JD; Collinge J
Arch Neurol; 2007 Dec; 64(12):1780-4. PubMed ID: 18071044
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease.
Sakai K; Hamaguchi T; Sanjo N; Murai H; Iwasaki Y; Hamano T; Honma M; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Kitamoto T; Harada M; Mizusawa H; Yamada M
J Neurol Sci; 2020 Nov; 418():117094. PubMed ID: 32823134
[TBL] [Abstract][Full Text] [Related]
35. Two distinct conformers of PrP
Cali I; Espinosa JC; Nemani SK; Marin-Moreno A; Camacho MV; Aslam R; Kitamoto T; Appleby BS; Torres JM; Gambetti P
Acta Neuropathol Commun; 2021 Mar; 9(1):55. PubMed ID: 33766126
[TBL] [Abstract][Full Text] [Related]
36. Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition.
Iwasaki Y; Imamura K; Iwai K; Kobayashi Y; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
Neuropathology; 2018 Oct; 38(5):549-556. PubMed ID: 30084170
[TBL] [Abstract][Full Text] [Related]
37. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.
Pastore M; Chin SS; Bell KL; Dong Z; Yang Q; Yang L; Yuan J; Chen SG; Gambetti P; Zou WQ
Am J Pathol; 2005 Dec; 167(6):1729-38. PubMed ID: 16314483
[TBL] [Abstract][Full Text] [Related]
38. Panencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene.
Marcon G; Indaco A; Di Fede G; Suardi S; Finato N; Moretti V; Micoli S; Fociani P; Zerbi P; Pincherle A; Redaelli V; Tagliavini F; Giaccone G
Brain Pathol; 2014 Mar; 24(2):148-51. PubMed ID: 24118545
[TBL] [Abstract][Full Text] [Related]
39. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein.
Kobayashi A; Iwasaki Y; Otsuka H; Yamada M; Yoshida M; Matsuura Y; Mohri S; Kitamoto T
Acta Neuropathol Commun; 2013 Nov; 1():74. PubMed ID: 24252157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
